BFRG
Bullfrog AI Holdings Inc (BFRG)
Healthcare • NASDAQ • $0.53+3.37%
- Symbol
- BFRG
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $0.53
- Daily Change
- +3.37%
- Market Cap
- $9.51M
- Trailing P/E
- N/A
- Forward P/E
- -3.02
- 52W High
- $1.96
- 52W Low
- $0.43
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- -2.74
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole, which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to …
Company websiteResearch BFRG on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.